Patents Assigned to NEW/ERA/MABS/GMBH
  • Publication number: 20230183654
    Abstract: The invention relates to an improved method for the selection of hybridoma cells from a plurality of hybridoma cells for the generation of monoclonal antibodies as well as hybridoma cells together with suitable expression vectors by means of intracellular biotinylation and the use thereof.
    Type: Application
    Filed: July 16, 2020
    Publication date: June 15, 2023
    Applicant: NEW/ERA/MABS GMBH
    Inventors: Katja HANACK, Martin LISTEK, Burkhard MICHEE
  • Patent number: 10526394
    Abstract: The invention relates, firstly, to a biomolecule-releasing cell characterised by a surface protein with an extracellularly exposed ligation peptide sequence for enzymatic conjugation of an adapter ligand, said adapter ligand being suitable for the indirect or direct coupling of a molecular catcher structure which has at least one specific binding site for the released biomolecules and which is at a distance from the specific binding site, secondly, to a method for selecting such a cell, and thirdly, to a means for this method comprising the surface protein that is characterised by an extracellularly exposable ligation peptide sequence for enzymatic conjugation of an adapter ligand, a nucleic acid coding for the surface protein, an expression vector for the nucleic acid, and a cell containing the expression vector.
    Type: Grant
    Filed: April 20, 2014
    Date of Patent: January 7, 2020
    Assignee: NEW / ERA / MABS GMBH
    Inventors: Martin Listek, Katja Hanack, Burkhard Micheel
  • Publication number: 20170044235
    Abstract: The invention relates, firstly, to a biomolecule-releasing cell characterised by a surface protein with an extracellularly exposed ligation peptide sequence for enzymatic conjugation of an adapter ligand, said adapter ligand being suitable for the indirect or direct coupling of a molecular catcher structure which has at least one specific binding site for the released biomolecules and which is at a distance from the specific binding site, secondly, to a method for selecting such a cell, and thirdly, to a means for this method comprising the surface protein that is characterised by an extracellularly exposable ligation peptide sequence for enzymatic conjugation of an adapter ligand, a nucleic acid coding for the surface protein, an expression vector for the nucleic acid, and a cell containing the expression vector.
    Type: Application
    Filed: April 20, 2014
    Publication date: February 16, 2017
    Applicant: NEW/ERA/MABS/GMBH
    Inventors: Martin LISTEK, Katja HANACK, Burkhard MICHEEL